Stockscreener 앱 받기
17.00
0.06%
0.01
시간 외 거래:
17.00
전일 마감가:
$16.99
열려 있는:
$17.11
하루 거래량:
339.70K
Relative Volume:
0.62
시가총액:
$1.03B
수익:
$688.00K
순이익/손실:
$-170.19M
주가수익비율:
-5.7432
EPS:
-2.96
순현금흐름:
$-154.68M
1주 성능:
+3.09%
1개월 성능:
+0.77%
6개월 성능:
-12.69%
1년 성능:
-39.37%
1일 변동 폭
$16.86
$17.58
1주일 범위
$16.12
$17.58
52주 변동 폭
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
명칭
Spyre Therapeutics Inc
전화
(617) 651-5940
주소
221 CRESCENT STREET, WALTHAM
SYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
17.00 | 1.03B | 688.00K | -170.19M | -154.68M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-08 | 개시 | Leerink Partners | Outperform |
| 2025-03-18 | 개시 | Wolfe Research | Outperform |
| 2024-09-04 | 개시 | Wedbush | Outperform |
| 2024-07-16 | 개시 | Evercore ISI | Outperform |
| 2024-05-02 | 개시 | Robert W. Baird | Outperform |
| 2024-03-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | 개시 | BTIG Research | Buy |
| 2023-12-11 | 개시 | Guggenheim | Buy |
| 2023-12-11 | 개시 | Jefferies | Buy |
| 2020-05-04 | 개시 | Piper Sandler | Overweight |
| 2019-03-21 | 개시 | JP Morgan | Overweight |
| 2018-09-04 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | 개시 | Evercore ISI | Outperform |
| 2018-03-14 | 재확인 | Needham | Buy |
모두보기
Spyre Therapeutics Inc 주식(SYRE)의 최신 뉴스
Chart Analysts Warn of Resistance Near Spyre Therapeutics Inc. Price2025 Trading Volume Trends & Verified Swing Trading Watchlist - beatles.ru
Tools to assess Spyre Therapeutics Inc.’s risk profileJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - Newser
Does Spyre Therapeutics Inc. stock benefit from AI growthWeekly Risk Report & Verified Momentum Watchlists - خودرو بانک
How to build a custom watchlist for Spyre Therapeutics Inc.Trade Ideas & Daily Oversold Bounce Ideas - Newser
Combining price and volume data for Spyre Therapeutics Inc.2025 EndofYear Setup & Trade Opportunity Analysis Reports - Newser
Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
How sensitive is Spyre Therapeutics Inc. to inflationMarket Activity Recap & Low Drawdown Trading Techniques - خودرو بانک
Does Spyre Therapeutics Inc. have high return on assetsJuly 2025 Update & Accurate Intraday Trade Tips - خودرو بانک
Can Spyre Therapeutics Inc. hit a new high this month2025 Market Overview & Real-Time Volume Analysis - Newser
Will Spyre Therapeutics Inc. rebound enough to break evenTrade Risk Report & Verified Technical Signals - Newser
Is it time to cut losses on Spyre Therapeutics Inc.July 2025 Reactions & Long-Term Growth Plans - Newser
What’s the RSI of Spyre Therapeutics Inc. stockMarket Weekly Review & Capital Protection Trading Alerts - khodrobank.com
Dow Update: Does Spyre Therapeutics Inc. align with a passive investing strategyMarket Activity Report & Fast Gain Swing Trade Alerts - خودرو بانک
Insider Trends: Can Spyre Therapeutics Inc. expand its profit marginsJuly 2025 Chart Watch & Fast Momentum Entry Tips - خودرو بانک
Chart based exit strategy for Spyre Therapeutics Inc.Trade Ideas & Risk Controlled Swing Trade Alerts - Newser
Published on: 2025-09-04 02:33:02 - Newser
Visualizing Spyre Therapeutics Inc. stock with heatmaps2025 Key Lessons & Weekly Breakout Stock Alerts - Newser
Relative strength of Spyre Therapeutics Inc. in sector analysisWeekly Trade Analysis & Reliable Intraday Trade Alerts - Newser
What technical models suggest about Spyre Therapeutics Inc.’s comebackWeekly Gains Report & Weekly Setup with High ROI Potential - Newser
CFO’s Major Stock Sale Shakes Up Spyre Therapeutics! - TipRanks
What is Spyre Therapeutics Inc.’s valuation compared to sectorWeekly Trade Analysis & Growth-Oriented Investment Plans - خودرو بانک
Can Spyre Therapeutics Inc. recover in the next quarter2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
Spyre Therapeutics Inc.’s volatility index tracking explainedWeekly Investment Summary & Low Risk Entry Point Guides - Newser
Combining machine learning predictions for Spyre Therapeutics Inc.Market Rally & Long-Term Safe Investment Ideas - Newser
Should you hold or exit Spyre Therapeutics Inc. now2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Custom watchlist performance reports with Spyre Therapeutics Inc.Portfolio Update Summary & Stepwise Swing Trade Plans - Newser
What are the future prospects of Spyre Therapeutics Inc.IPO Watch & Proven Capital Preservation Methods - خودرو بانک
Spyre Therapeutics Inc. stock trend forecastEarnings Growth Report & Smart Investment Allocation Insights - Newser
Is Spyre Therapeutics Inc. stock a buy or sell2025 Dividend Review & Low Risk High Win Rate Picks - خودرو بانک
Does Spyre Therapeutics Inc. align with a passive investing strategyJuly 2025 PreEarnings & Low Risk High Win Rate Picks - خودرو بانک
Is Spyre Therapeutics Inc. trending in predictive chart models2025 Price Action Summary & Safe Swing Trade Setup Alerts - Newser
Is Spyre Therapeutics Inc. benefiting from interest rate changesJuly 2025 Sector Moves & Verified Chart Pattern Trade Signals - خودرو بانک
Can Spyre Therapeutics Inc. disrupt its industryPortfolio Return Report & Accurate Intraday Trading Signals - خودرو بانک
Can Spyre Therapeutics Inc. withstand a market correctionMarket Rally & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Published on: 2025-09-01 18:05:22 - خودرو بانک
Will Spyre Therapeutics Inc. bounce back from current supportWeekly Trade Review & Verified Short-Term Plans - Newser
Real time scanner hits for Spyre Therapeutics Inc. explainedMarket Movement Recap & Entry Point Confirmation Signals - Newser
Spyre Therapeutics (NASDAQ:SYRE) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Will a bounce in Spyre Therapeutics Inc. offer an exitDividend Hike & Smart Money Movement Alerts - Newser
What high frequency data says about Spyre Therapeutics Inc.July 2025 Volume & Capital Efficient Trading Techniques - Newser
Spyre Therapeutics Inc (SYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):